| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | SELL | BUY | BUY |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 3.65▼ | 3.69▼ | 3.70▼ | 3.61▼ | 2.93▲ |
| MA10 | 3.66▼ | 3.73▼ | 3.73▼ | 3.56▲ | 2.11▲ |
| MA20 | 3.70▼ | 3.73▼ | 3.67▼ | 2.98▲ | 1.86▲ |
| MA50 | 3.74▼ | 3.70▼ | 3.63▼ | 1.98▲ | 2.39▲ |
| MA100 | 3.69▼ | 3.61▼ | 3.29▲ | 1.81▲ | 2.46▲ |
| MA200 | 3.70▼ | 3.18▲ | 2.47▲ | 2.21▲ | 6.49▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.009▼ | -0.017▼ | -0.008▼ | 0.019▲ | 0.304▲ |
| RSI | 28.166▼ | 41.036▼ | 44.859▼ | 69.584▲ | 70.247▲ |
| STOCH | 13.611▼ | 27.099 | 52.719 | 76.855 | 83.641▲ |
| WILL %R | -100.000▼ | -100.000▼ | -46.226 | -22.674▲ | -13.356▲ |
| CCI | -180.997▼ | -206.930▼ | -39.598 | 71.716 | 175.914▲ |
|
Friday, June 13, 2025 03:01 AM
ADC Therapeutics SA (NYSE: ADCT), a commercial-stage global leader and pioneer in the field of antibody drug conjugates (ADCs), today announced updated data from the LOTIS-7 Phase 1b open-label ...
|
|
Thursday, June 12, 2025 07:59 AM
ADC Therapeutics (NYSE:ADCT), on Thursday, reported results from an early stage trial testing its antibody drug conjugate, Zynlonta, in combination with the bispecific antibody glofitamab to treat ...
|
|
Thursday, June 05, 2025 04:59 PM
ADC Therapeutics SA (NYSE: ADCT), a commercial-stage global leader and pioneer in the field of antibody drug conjugates (ADCs), today announced that the Company has made grants of options to ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 13/06/25 | 3.57 | 3.97 | 3.57 | 3.58 | 829,422 |
| 12/06/25 | 3.45 | 3.88 | 3.29 | 3.67 | 737,274 |
| 11/06/25 | 3.76 | 3.82 | 3.53 | 3.53 | 470,374 |
| 10/06/25 | 3.705 | 3.845 | 3.665 | 3.69 | 656,668 |
| 09/06/25 | 3.81 | 3.81 | 3.555 | 3.57 | 757,104 |
| 06/06/25 | 3.52 | 3.745 | 3.441 | 3.67 | 707,321 |
| 05/06/25 | 3.35 | 3.56 | 3.21 | 3.44 | 635,930 |
| 04/06/25 | 3.53 | 3.5355 | 3.26 | 3.34 | 802,600 |
| 03/06/25 | 3.60 | 3.85 | 3.40 | 3.59 | 1,734,805 |
| 02/06/25 | 3.12 | 3.57 | 2.88 | 3.51 | 1,694,186 |
|
|
||||
|
|
||||
|
|